# OSU6162 in Bipolar Depression (OBID)

> **NCT05296356** · PHASE2 · RECRUITING · sponsor: **Göteborg University** · enrollment: 22 (estimated)

## Conditions studied

- Bipolar Depression

## Interventions

- **DRUG:** OSU6162

## Key facts

- **NCT ID:** NCT05296356
- **Lead sponsor:** Göteborg University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-25
- **Primary completion:** 2026-05-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2025-03-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05296356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05296356, "OSU6162 in Bipolar Depression (OBID)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05296356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*